SMTL ID : 2ycr.1

Crystal structure of checkpoint kinase 2 in complex with inhibitor PV976

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

2 x HCW: 1,3-BIS{4-[(1E)-N-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)ETHANEHYDRAZONOYL]PHENYL}UREA(Non-covalent)

HCW.1: 14 residues within 4Å: Chain A: K.16, L.18, V.26, K.41, I.43, E.65, L.93, M.96, E.97, G.99, L.146, T.159, D.160, G.162 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.18, A:V.26, A:K.41, A:L.93, A:L.146 Hydrogen bonds: A:E.65, A:D.160, A:D.160, A:G.162 Water bridges: A:E.100, A:E.100 HCW.3: 14 residues within 4Å: Chain B: K.16, L.18, V.26, K.41, I.43, E.65, L.93, M.96, E.97, G.99, L.146, T.159, D.160, G.162 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:L.18, B:V.26, B:K.41, B:L.93, B:L.146 Hydrogen bonds: B:E.65, B:D.160, B:G.162 Water bridges: B:E.100

2 x NO3: NITRATE ION(Non-functional Binders)

NO3.2: 5 residues within 4Å: Chain A: L.167, G.195, Y.196, N.197, R.198 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:N.197, A:N.197, A:R.198, A:R.198, A:R.198 NO3.4: 5 residues within 4Å: Chain B: L.167, G.195, Y.196, N.197, R.198 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:N.197, B:N.197, B:R.198, B:R.198, B:R.198

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lountos, G.T. et al., Structural Characterization of Inhibitor Complexes with Checkpoint Kinase 2 (Chk2), a Drug Target for Cancer Therapy. J.Struct.Biol. (2011)

Release Date

2011-11-16

Peptides

SERINE/THREONINE-PROTEIN KINASE CHK2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

SERINE/THREONINE-PROTEIN KINASE CHK2